KOPRANNSEKopran Limited· PharmaceuticalsMediumNeutral
Announced Thu, 30 Apr · 18:25 IST

Kopran Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on Jun 03, 2026

Nclt Scheme FiledStrategic Transactions View source PDF

KOPRAN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.6%1-day move
₹164.90
prior close
₹168.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.4-0.4+0.3+0.4-0.6-0.3+0.3-2.0-3.8-6.2+14.6+12.2+18.1
Up moveDown movePending
AI summary

Kopran Limited has issued notices for court-convened meetings on June 3, 2026, to seek approval for a Scheme of Amalgamation (Merger by Absorption). Under this scheme, Kopran Laboratories Limited (Transferor Company) will merge into Kopran Limited (Transferee Company). The meetings are being held for Equity Shareholders, Secured Creditors, and Unsecured Creditors of both companies, scheduled across the day through VC/OAVM mode. The NCLT Mumbai Bench passed the order on April 9, 2026, and the notices are being dispatched to shareholders and creditors from April 30, 2026.

Likely market impact

The merger of Kopran Laboratories into Kopran Limited could streamline operations and reduce group complexity, potentially benefiting shareholders of the surviving entity. However, the share swap or other merger terms have not been disclosed in this notice.